Substituted diphenyl derivatives
AssigneeCreative Therapeutics GmbH
InventorHeinz Förster
Life of this patent
Estimating the term…
Abstract
Triazene-substituted diphenyl derivatives are suitable as chemotherapeutic agents for treating carcinomas in humans and animals.
Claims11
1-12. (canceled)
A diphenyl derivative containing
- (i) at least a dialkyltriazenyl group,
- (ii) at least one sulfooxy group and/or at least one sulfamoyloxy group per molecule, and
- its salts, solvates and solvates of these salts.
The diphenyl derivative as claimed in claim 1, the diphenyl derivative having the formula 4-(3,3-dimethyltriazenyl-1)-4′-sodiosulfooxybenzophenone
A process for preparing diphenyl derivatives containing (i) at least one dialkyltriazenyl group and (ii) at least one sulfooxy group and/or at least one sulfamoyloxy group per molecule and their salts, solvates and solvates of these salts, wherein:
- aminophenyl derivatives of the formula
- where
- X is a direct C—C bond, CH2, CHOH, CO, S, SO, SO2, —N═N—, —CR7═CR8— or
- a divalent —C(O)—C*═CH—O— radical which together with the two adjacent carbon atoms of the ring a on which it is located forms a pyranone ring, with the ring b being located on the C* atom of this radical,
- R3, R6 are each, independently of one another, hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkyl-S—, C1-C4-alkyl-SO—, C1-C4-alkyl-SO2—, halogen, nitro, cyano or an —OSO2Y group,
- R4, R5 are each, independently of one another, an —NH2 group or an —OSO2Y group,
- R7 is hydrogen, methyl, ethyl or a phenyl radical which is substituted by the radicals R9, R10 and is bound directly to the R7-bearing carbon atom,
- R8 is hydrogen, ethyl, CN, NO2, —CH2CH2-halogen or CH2CH2OH,
- R9, R10 are each, independently of one another, hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, halogen, nitro, cyano, an —NH2 group or an —OSO2Y group,
- Y is OH or N(R1)2, and
- R1 is hydrogen, methyl or ethyl,
- with the proviso that, per total molecule (2), one or two NH2 groups and one or two —OSO2Y groups are located on any ring carbons of aromatic rings,
- are diazotized by means of a diazotizing agent in the presence of strong acid at low temperature in aqueous-acidic solution to form diazonium salts of the formula
- where
- X is a direct C—C bond, CH2, CHOH, CO, S, SO, SO2, —N═N—, —CR7═CR8— or
- a divalent —C(O)—C*═CH—O— radical which together with the two adjacent carbon atoms of the ring a on which it is located forms a pyranone ring, with the ring b being located on the C* atom of this radical,
- R3, R6 are each, independently of one another, hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkyl-S—, C1-C4-alkyl-SO_, C1-C4-alkyl-SO2—, halogen, nitro, cyano or an —OSO2Y group,
- R4, R5 are each, independently of one another, an —N2+AN− group or an —OSO2Y group,
- R7 is hydrogen, methyl, ethyl or a phenyl radical which is substituted by the radicals R9, R10 and is bound directly to the R7-bearing carbon atom,
- R8 is hydrogen, ethyl, CN, NO2, —CH2CH2-halogen or CH2CH2OH,
- R9, R10 are each, independently of one another, hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, halogen, nitro, cyano, an —N2+An− group or an —OSO2Y group,
- An− is a halogen anion or ½ sulfate (SO42−) anion,
- Y is OH or N(R1)2, and
- R1 is hydrogen, methyl or ethyl,
- with the proviso that, per total molecule (3), one or two diazonium groups and one or two —OSO2Y groups are located on any ring carbons of aromatic rings,
- and the diazonium salts (3) obtained are then reacted with dialkylamines of the formula
- HN(R2)2 (4)
- where R2 is methyl or ethyl,
- in the presence of acid binding agents,
- optionally followed by preparation of the salts from the compounds obtained and optionally followed by setting-free of the hydroxyl and/or acid groups from these salts.
A method of combating tumors of the skin and of the target organs dependent on sex hormones in human beings and animals by administration of a sufficient amount of at least one diphenyl derivative containing (i) at least one dialkyltriazenyl group, (ii) at least one sulfooxy group and/or at least one sulfamoyloxy group per molecule and its salts, solvates and solvates of these salts.
A medicament containing at least one of the diphenyl derivatives containing (i) at least one dialkyltriazenyl group, (ii) at least one sulfooxy group and/or at least one sulfamoyloxy group per molecule and their salts, solvates and solvates of these salts, optionally together with one or more pharmacologically acceptable auxiliaries or supports.
Dependencies are inferred from the claim text.